Sumanta Pal Selected Research

Sumanta Pal Research Topics

Disease

30	Neoplasms (Cancer) 12/2022 - 09/2009
19	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 10/2014
11	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 02/2014
8	Carcinoma (Carcinomatosis) 12/2021 - 01/2016
4	Breast Neoplasms (Breast Cancer) 01/2017 - 09/2009
3	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2011
3	Fatigue 01/2020 - 07/2016
3	Nausea 02/2019 - 07/2012
3	Disease Progression 01/2017 - 01/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 12/2021 - 01/2021
2	COVID-19 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2020 - 07/2016
2	Adenocarcinoma 10/2019 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 02/2013
1	Lymphadenopathy 03/2022
1	Infections 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 12/2021
1	Renal Insufficiency (Renal Failure) 01/2020
1	Urologic Neoplasms (Urological Cancer) 10/2019
1	Dyspnea (Shortness of Breath) 10/2018
1	Diarrhea 10/2018
1	Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell) 12/2017

Drug/Important Bio-Agent (IBA)

9	cabozantinibIBA 03/2022 - 07/2016
8	Everolimus FDA Link 09/2021 - 03/2015
6	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2017
4	atezolizumabIBA 03/2022 - 01/2020
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2016
4	PlatinumIBA 06/2021 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 01/2016
3	NivolumabIBA 01/2022 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2019
2	Hormones (Hormone)IBA 11/2022 - 03/2022
2	AndrogensIBA 11/2022 - 01/2020
2	enzalutamideIBA 03/2022 - 01/2022
2	abirateroneIBA 03/2022 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2016
2	IpilimumabIBA 01/2022 - 01/2020
2	COVID-19 VaccinesIBA 05/2021 - 01/2021
2	Axitinib (AG 013736)IBA 01/2021 - 03/2015
2	CytokinesIBA 01/2021 - 01/2017
2	CreatinineIBA 01/2020 - 02/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 02/2014
2	MTOR InhibitorsIBA 06/2019 - 01/2016
2	Phosphotransferases (Kinase)IBA 06/2019 - 11/2011
2	Sunitinib (Sutent)FDA Link 02/2019 - 03/2015
2	Sorafenib (BAY 43-9006)FDA Link 02/2019 - 03/2015
2	OligonucleotidesIBA 01/2017 - 02/2013
2	Estrogen ReceptorsIBA 01/2017 - 09/2009
2	Proteins (Proteins, Gene)FDA Link 02/2014 - 02/2013
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2022
1	pembrolizumabIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	SteroidsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 12/2021
1	Circulating Tumor DNAIBA 12/2021
1	avelumabIBA 06/2021
1	Carboplatin (JM8)FDA LinkGeneric 06/2021
1	VaccinesIBA 01/2021
1	carotuximabIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	sipuleucel-T (APC8015)FDA Link 01/2021
1	EndoglinIBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	FluoridesIBA 01/2020
1	cyclopropapyrroloindoleIBA 11/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2019
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2019
1	Sirolimus (Rapamycin)FDA Link 06/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2019
1	pazopanib FDA Link 02/2019
1	AngiopoietinsIBA 02/2019
1	trebananibIBA 02/2019
1	Bevacizumab (Avastin)FDA Link 02/2019
1	AntigensIBA 01/2018
1	Antisense OligonucleotidesIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Chimeric Antigen ReceptorsIBA 01/2018
1	apatorsenIBA 01/2018
1	alectinibIBA 12/2017
1	CrizotinibIBA 12/2017
1	Anaplastic Lymphoma KinaseIBA 12/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017

Therapy/Procedure

26	Therapeutics 12/2022 - 09/2009
11	Drug Therapy (Chemotherapy) 01/2022 - 09/2009
5	Immunotherapy 01/2020 - 12/2015
3	Castration 03/2022 - 01/2021
3	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2018
2	Radiotherapy 12/2022 - 11/2022
2	Cystectomy 12/2021 - 01/2016
2	Lymph Node Excision (Lymph Node Dissection) 09/2018 - 01/2018
2	Adjuvant Chemotherapy 07/2012 - 09/2009
1	Neoadjuvant Therapy 12/2021
1	Combination Drug Therapy (Combination Chemotherapy) 10/2019
1	Ligation 12/2017